“Kids shouldn't have to struggle in silence,” the boy's mother said ...

Today, 11-year-old Logan Fitzpatrick of Malverne, New York, spends his time playing baseball, practicing tae kwon do, ...

CytoAgents, Inc., a clinical-stage biotechnology company at the forefront of immunologic research, today announced the addition of two distinguished scientists to its Scientific Advisory Board (SAB): ...

Renexxion plans to file new drug application (NDA) with the Food and Drug Administration (FDA) using future Phase 3 results ROSCREA, Ireland and ...

APEX Part B met all primary and secondary endpoints with high statistical significance; mid-dose zumilokibart planned to advance into Phase 3 ...

Jefferies Global Healthcare Conference 2026 June 4, 2026 9:55 AM EDTCompany ParticipantsPeter Griffith - Executive VP & ...

While gastric acid-reducing medications (ARMs) such as proton pump inhibitors (PPIs) and histamine-2 receptor antagonists ...

Key Points Interested in Apogee Therapeutics Inc.? Here are five stocks we like better. Apogee Therapeutics plans to advance ...

Detailed price information for Eupraxia Pharmaceuticals Inc (EPRX-Q) from The Globe and Mail including charting and trades.

A new study has found a clear link between air pollution exposure and the risk of ending up in hospital. It's a battle Julia Ovens knows only too well.

Eosinophilic AE-COPD is associated with a lower risk for major adverse cardiovascular events (MACE) compared with noneosinophilic AE-COPD.

Stanford Medicine researchers and their colleagues found that a new drug, obexelimab, significantly reduces the risk of ...